Table 1. Summary table of the characteristics and key findings of significant studies mentioned in this narrative review.
Primary study | Country | Type of study | Population size | Outcomes | Ref. |
---|---|---|---|---|---|
CT scan studies | |||||
Zhu et al. | China | Meta-analysis | 4121 | The results of the meta-analysis showed that most patients presented bilateral lung involvement (73.8%) or multilobar involvement (67.3%). The most common changes in lesion density were GGOs (68.1%). In addition, the paper recommends using CT for screening patients with a negative RT-PCR result who have epidemiological and clinical features of COVID-19. | [10] |
Xu et al. | China, Japan | Meta-analysis | 3186 | Sixteen studies were included in the meta-analysis. CT sensitivity was 92% (95% CI: 86–96%), and two studies reported specificity (25% [95% CI: 22–30%] and 33% [95% CI: 23–44%], respectively). There was substantial heterogeneity according to Cochran's Q test (p < 0.01) and Higgins I2 heterogeneity index (96% for sensitivity). Based on study site, the sensitivity of chest CT was great in Wuhan and the sensitivity values were very close to each other (97, 96 and 99%, respectively). In the regions other than Wuhan, the sensitivity varied from 61 to 98%. | [16] |
Adams et al. | China, Italy, Japan | Meta-analysis | 1431 | Six studies were included in the meta-analysis. The sensitivity of chest CT ranged from 92.9 to 97.0%, and specificity ranged from 25.0 to 71.9%, with pooled estimates of 94.6% (95% CI: 91.9–96.4%) and 46.0% (95% CI: 31.9–60.7%), respectively. The included studies were statistically homogeneous in their estimates of sensitivity (p = 0.578) and statistically heterogeneous in their estimates of specificity (p < 0.001). Chest CT appears to have a relatively high sensitivity in symptomatic patients at high risk of COVID 19, however, specificity is poor. | [19] |
Kanne et al. | China | Retrospective study | 9720 | The most common presentations were fever (98%), cough (76%) and myalgia or fatigue (44%). Dyspnea has been reported in 55% of patients. CT findings were 86% GGOs and 29% consolidation | [18] |
Ai et al. | China | Retrospective study | 1014 | Fifty-nine percent had positive RT-PCR results, and 88% had positive chest CT scans. The sensitivity of chest CT in suggesting COVID-19 was 97% based on positive RT-PCR results. In patients with initial negative RT-PCR results, 75% had positive chest CT findings. In patients with negative RT-PCR results but positive chest CT scans (n = 308 patients), 48% (147/308) of patients were re-considered as highly likely cases, with 33% (103/308) as probable cases by a comprehensive evaluation. | [2] |
Bai et al. | USA & China | Retrospective study | 219 | The most discriminating features for COVID-19 pneumonia included a peripheral distribution (80 vs 57%; p < 0.001), GGO (91 vs 68%; p < 0.001) and vascular thickening (58 vs 22%; p < 0.001). Three Chinese radiologists had sensitivities of 72, 72 and 94% and specificities of 94, 88 and 24%. Four US radiologists had sensitivities of 93, 83, 73 and 73% and specificities of 100, 93, 93 and 100%. | [21] |
Zhao et al. | China | Retrospective study | 101 | A total of 70.2% of the patients were 21–50 years old. 78.2% had fever as the onset symptom. GGO 86.1% or mixed GGO and consolidation 64.4%, vascular enlargement in the lesion 71.3%. Lesions present on CT images were more likely to have a peripheral distribution 87.1% | [7] |
Xie et al. | China | Retrospective study | 167 | The RT-PCR and CT were concordant for 2019-nCoV infection in 93%. Three percent of the patients initially had negative RT-PCR but positive chest CT with pattern consistent with viral pneumonia. Four percent had a negative chest CT with a positive RT-PCR. | [17] |
Song et al. | China | Retrospective study | 51 | Chest CT showed pure GGOs in 77% of patients, GGOs with interstitial and/or interlobular septal thickening in 75% of patients, and GGOs with consolidation in 59% of patients. At chest CT, GGOs were bilateral in 88% of patients, involving the posterior lungs in 82% and the peripheral lungs in 85% of patients. | [12] |
Fang et al. | China | Retrospective study | 51 | Seventy-one percent of the patients had initial positive RT-PCR for COVID-19.Twenty-four percent of the patients had COVID-19 confirmed by two RT-PCR nucleic acid tests (1–2 days), (72%) had typical CT manifestations such as GGO's and consolidation. | [14] |
Chest x-ray studies | |||||
Wang et al. | Canada | Dataset | 13870 | COVID-Net is one of the first open source network designs for COVID-19 detection from CXR images at the time of initial release. The introduction of COVIDx, an open access benchmark dataset. The dataset has the largest number of publicly available COVID-19 positive cases to the best of the authors’ knowledge. | [22] |
Wong et al. | Hong Kong, China | Retrospective study | 64 | In a cohort of patients with COVID-19 infection and imaging follow-up, baseline chest x-ray had a sensitivity of 69%, compared with 91% for initial RT-PCR. Chest x-ray abnormalities preceded positive RT-PCR in 6/64 (9%) patients. Common chest x-ray findings mirror those previously described for CT: bilateral, peripheral, consolidation and/or GGO. |
[23] |
Using PubMed and Google Scholar, studies that were included were based on the following search strategy; COVID-19, CT scan, CXRs, RT-PCR and imaging. We excluded studies that did not address the topic of interest.
COVID-19: Novel coronavirus disease 2019; CT: Computed tomography; CXR: Chest x-ray; GGO: Ground-glass opacity; RT-PCR: Reverse transcriptase PCR.